3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Other neoplasm
1
Conditions
Precancerous Conditions
1
Esophageal Neoplasms
1
Barrett Esophagus
1
Interventions
Endoscopy
2
Biopsy
2
Immunohistochemistry
1
High-Throughput Screening Assays
1
Genetic Linkage
1
Esomeprazole
1
Erlotinib Hydrochloride
1
Endoscopy, Digestive System
1
Endoscopic Mucosal Resection
1
Comparative Genomic Hybridization
1
Aspirin
1
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Esomeprazole
×
Other neoplasm
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts